3-N-Cyclopentylpyridine-2,3-diamine
![]() |
- $194 - $511
- Product name: 3-N-Cyclopentylpyridine-2,3-diamine
- CAS: 1286273-74-2
- MF: C10H15N3
- MW: 177.25
- EINECS:
- MDL Number:MFCD20688650
- Synonyms:3-N-Cyclopentylpyridine-2,3-diamine;2,3-Pyridinediamine, N3-cyclopentyl-;N3-cyclopentylpyridine-2,3-diamine
4 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product number3507AD
- Product description3-N-Cyclopentylpyridine-2,3-diamine
- Packaging500mg
- Price$311
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11300393
- Product descriptionN3-Cyclopentylpyridine-2,3-diamine 95+%
- Packaging5g
- Price$511
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number076906
- Product description3-N-Cyclopentylpyridine-2,3-diamine 97%
- Packaging500mg
- Price$194
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number076906
- Product description3-N-Cyclopentylpyridine-2,3-diamine 97%
- Packaging1g
- Price$245
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 3507AD | 3-N-Cyclopentylpyridine-2,3-diamine | 500mg | $311 | 2021-12-16 | Buy |
Crysdot | CD11300393 | N3-Cyclopentylpyridine-2,3-diamine 95+% | 5g | $511 | 2021-12-16 | Buy |
Matrix Scientific | 076906 | 3-N-Cyclopentylpyridine-2,3-diamine 97% | 500mg | $194 | 2021-12-16 | Buy |
Matrix Scientific | 076906 | 3-N-Cyclopentylpyridine-2,3-diamine 97% | 1g | $245 | 2021-12-16 | Buy |
Properties
Boiling point :345.9±27.0 °C(Predicted)
Density :1.188±0.06 g/cm3(Predicted)
pka :6.83±0.36(Predicted)
Density :1.188±0.06 g/cm3(Predicted)
pka :6.83±0.36(Predicted)
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|